Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAM | P19021 | 2/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 5/20 | 0.37 |
| ▸ | CES1 | P23141 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26978208 | 0.92 | AKR1B1 (0.43) | PAMALDH1A1AKR1B1TSHRSLC22A6 | |
| SCHEMBL11820606 | 0.92 | PAM (0.48) | PAMDGKACES2CES1ALDH1A1 | |
| SCHEMBL20918464 | 0.90 | DGKA (0.52) | PAMDGKACES2CES1ALDH1A1 | |
| SCHEMBL28727569 | 0.87 | CA1 (0.39) | PAMDGKACES2CES1ALDH1A1 | |
| SCHEMBL29166841 | 0.87 | NAAA (0.42) | PAMDGKACES2CES1ALDH1A1 | |
| SCHEMBL26767143 | 0.87 | CYP1A2 (0.48) | PAMDGKAALDH1A1LMNAHTR2C | |
| SCHEMBL26978207 | 0.87 | TSHR (0.47) | PAMALDH1A1AKR1B1TSHRSLC22A6 | |
| SCHEMBL15093590 | 0.87 | LMNA (0.34) | PAMDGKACES2CES1ALDH1A1 | |
| SCHEMBL645760 | 0.86 | ALDH1A1 (0.39) | DGKACES2CES1ALDH1A1LMNA | |
| SCHEMBL28949796 | 0.86 | DGKA (0.52) | PAMDGKACES2CES1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2723750-B1 | DIKETOPYRROLOPYRROLE OLIGOMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES | CLAP CO LTD (KR) | 2022-08-10 | — | — | EP | disclosed |
| EP-2751855-B1 | DIKETOPYRROLOPYRROLE OLIGOMERS AND COMPOSITIONS, COMPRISING DIKETOPYRROLOPYRROLE OLIGOMERS | BASF SE (DE) | 2020-10-28 | — | — | EP | disclosed |
| EP-2216312-B1 | PROCESS FOR PRODUCING ORGANIC COMPOUND | M TECHNIQUE CO LTD (JP) | 2019-05-01 | — | — | EP | disclosed |
| EP-2184109-B1 | METHOD FOR PRODUCING NANOPARTICLES BY FORCED ULTRA-THIN FILM ROTARY PROCESSING | M TECHNIQUE CO LTD (JP) | 2017-08-23 | — | — | EP | disclosed |
| US-9211510-B2 | Method for producing nanoparticles by forced ultrathin film rotary processing | M. TECHNIQUE CO., LTD. (JP) | 2015-12-15 | — | — | US | disclosed |
| US-9209412-B2 | Diketopyrrolopyrrole oligomers and compositions, comprising diketopyrrolopyrrole oligomers | BASF SE (DE) | 2015-12-08 | — | — | US | disclosed |
| US-8883889-B2 | Pigment compositions comprising pyrrolo[3,4-c]pyrroles | BASF SE (DE) | 2014-11-11 | — | — | US | disclosed |
| US-20140217329-A1 | DIKETOPYRROLOPYRROLE OLIGOMERS AND COMPOSITIONS, COMPRISING DIKETOPYRROLOPYRROLE OLIGOMERS | UNIVERSITE LIBRE DE BRUXELLES (BE) | 2014-08-07 | — | — | US | disclosed |
| US-20140206670-A1 | COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS | PFIZER INC. (US) | 2014-07-24 | — | — | US | disclosed |
| EP-2751855-A1 | DIKETOPYRROLOPYRROLE OLIGOMERS AND COMPOSITIONS, COMPRISING DIKETOPYRROLOPYRROLE OLIGOMERS | BASF SE (DE) | 2014-07-09 | — | — | EP | disclosed |
| EP-0962499-B1 | Direct preparation of pigmentary pyrrolo-(3,4-C)pyrroles | CIBA SC HOLDING AG (CH) | 2003-03-05 | — | — | EP | disclosed |
| US-6361594-B1 | ONE-STEP PROCESS USING CRYSTAL GROWTH INHIBITORS DURING SYNTHESIS; NO SIZE REDUCTION NEEDED; HIGH DISPERSABILITY, TINCTORIAL STRENGTH, PURITY, AND MIGRATION, HEAT, LIGHT AND WEATHERING FASTNESS | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-03-26 | — | — | US | disclosed |
| US-20020010331-A1 | Reacting succinic diester with nitrile | CLARIANT GMBH | 2002-01-24 | — | — | US | disclosed |
| US-6057449-A | HEATING A DISUCCINATE WITH A NITRILE IN THE PRESENCE OF BASE | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0962499-A2 | Direct preparation of pigmentary pyrrolo-(3,4-C)pyrroles | Ciba SC Holding AG (CH) | 1999-12-08 | — | — | EP | disclosed |
| US-5492564-A | HIGH OPACITY, COLORFASTNESS | CIBA-GEIGY CORPORATION (US) | 1996-02-20 | — | — | US | disclosed |
| US-4749795-A | Phenyl substituted pyrrolinones | CIBA-GEIGY CORPORATION (US) | 1988-06-07 | — | — | US | disclosed |
| US-4720305-A | Mixtures of pigments | CIBA-GEIGY CORPORATION (US) | 1988-01-19 | — | — | US | disclosed |
| US-4681971-A | Phenyl substituted aminodicarboxylate esters | CIBA-GEIGY CORPORATION (US) | 1987-07-21 | — | — | US | disclosed |
| US-4579949-A | REACTING DISUCCINATE WITH NITRILES | CIBA-GEIGY CORPORATION (US) | 1986-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010331-A1 | Reacting succinic diester with nitrile | SDHA, QDPR, SDHB | PAM 3134/4885DGKA 954/4885CES2 3450/4885 |
| US-20140206670-A1 | COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS | SLC6A2, OPRD1, ADRB2 | PAM 4073/4885DGKA 403/4885CES2 1246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.